EGT transfers clinical grade lentiviral vector to MSKCC

[News]

Errant Gene Therapeutics, LLC, a pioneering boutique drug development firm specializing in Rare Diseases, announced the transfer of its clinical grade lentiviral vector, TNS 9.55.3, to Memorial Sloan Kettering Cancer Center.

More... (http://www.news-medical.net/news/20110729/EGT-transfers-clinical-grade-lentiviral-vector-to-MSKCC.aspx)